🇺🇸 FDA
Pipeline program

Methotrexate - Amneal

15-VIN-515

Phase 1 small_molecule active

Quick answer

Methotrexate - Amneal for Psoriasis is a Phase 1 program (small_molecule) at Amneal Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
Amneal Pharmaceuticals
Indication
Psoriasis
Phase
Phase 1
Modality
small_molecule
Status
active

Clinical trials